These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 32745834)

  • 1. Psychotic late-life depression less likely to relapse after electroconvulsive therapy.
    Wagenmakers MJ; Oudega ML; Vansteelandt K; Spaans HP; Verwijk E; Obbels J; Rhebergen D; van Exel E; Bouckaert F; Stek ML; Sienaert P; Dols A
    J Affect Disord; 2020 Nov; 276():984-990. PubMed ID: 32745834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Which residual symptoms predict relapse after successful electroconvulsive therapy for late-life depression?
    Lambrichts S; Vansteelandt K; Hebbrecht K; Wagenmakers MJ; Oudega ML; Obbels J; van Exel E; Dols A; Bouckaert F; Schrijvers D; Verwijk E; Sienaert P
    J Psychiatr Res; 2022 Oct; 154():111-116. PubMed ID: 35933854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Remission Rates Following Electroconvulsive Therapy and Relation to Index Episode Duration in Patients With Psychotic Versus Nonpsychotic Late-Life Depression.
    Wagenmakers MJ; Oudega ML; Bouckaert F; Rhebergen D; Beekman ATF; Veltman DJ; Sienaert P; van Exel E; Dols A
    J Clin Psychiatry; 2022 Aug; 83(5):. PubMed ID: 35950901
    [No Abstract]   [Full Text] [Related]  

  • 4. Long-term Outcome Following Electroconvulsive Therapy for Late-Life Depression: Five-Year Follow-up Data From the MODECT Study.
    Lambrichts S; Wagenmakers MJ; Vansteelandt K; Obbels J; Schouws SNTM; Verwijk E; van Exel E; Bouckaert F; Vandenbulcke M; Schrijvers D; Veltman DJ; Beekman ATF; Oudega ML; Sienaert P; Dols A
    Am J Geriatr Psychiatry; 2022 Dec; 30(12):1283-1294. PubMed ID: 35667960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical characteristics associated with relapse 2 years after electroconvulsive therapy for major depression.
    Pluijms EM; Vinther PT; Kamperman AM; Birkenhäger TK
    Acta Psychiatr Scand; 2023 Jun; 147(6):561-569. PubMed ID: 36938869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. One-year outcome of psychotic depression after successful electroconvulsive therapy.
    Birkenhäger TK; van den Broek WW; Mulder PG; de Lely A
    J ECT; 2005 Dec; 21(4):221-6. PubMed ID: 16301881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BrainAge of patients with severe late-life depression referred for electroconvulsive therapy.
    Wagenmakers MJ; Oudega ML; Klaus F; Wing D; Orav G; Han LKM; Binnewies J; Beekman ATF; Veltman DJ; Rhebergen D; van Exel E; Eyler LT; Dols A
    J Affect Disord; 2023 Jun; 330():1-6. PubMed ID: 36858270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Electroconvulsive therapy response in late-life depression unaffected by age-related brain changes.
    Bouckaert F; Emsell L; Vansteelandt K; De Winter FL; Van den Stock J; Obbels J; Dols A; Stek M; Adamczuk K; Sunaert S; Van Laere K; Sienaert P; Vandenbulcke M
    J Affect Disord; 2019 May; 251():114-120. PubMed ID: 30921594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship Between Hippocampal Volume, Serum BDNF, and Depression Severity Following Electroconvulsive Therapy in Late-Life Depression.
    Bouckaert F; Dols A; Emsell L; De Winter FL; Vansteelandt K; Claes L; Sunaert S; Stek M; Sienaert P; Vandenbulcke M
    Neuropsychopharmacology; 2016 Oct; 41(11):2741-8. PubMed ID: 27272769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relapse and long-term cognitive performance after brief pulse or ultrabrief pulse right unilateral electroconvulsive therapy: A multicenter naturalistic follow up.
    Verwijk E; Spaans HP; Comijs HC; Kho KH; Sienaert P; Bouckaert F; Obbels J; Scherder EJ; Stek ML; Kok RM
    J Affect Disord; 2015 Sep; 184():137-44. PubMed ID: 26093032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MADRS symptom subtypes in ECT-treated depressed patients: relationship to response and subsequent ECT.
    Spashett R; Fernie G; Reid IC; Cameron IM
    J ECT; 2014 Sep; 30(3):227-31. PubMed ID: 24831998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Individualized continuation electroconvulsive therapy and medication as a bridge to relapse prevention after an index course of electroconvulsive therapy in severe mood disorders: a naturalistic 3-year cohort study.
    Odeberg H; Rodriguez-Silva B; Salander P; Mårtensson B
    J ECT; 2008 Sep; 24(3):183-90. PubMed ID: 18695624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of vascular risk factors on clinical outcome in elderly patients with depression receiving electroconvulsive therapy.
    Jurek L; Dorey JM; Nourredine M; Galvao F; Brunelin J
    J Affect Disord; 2021 Jan; 279():308-315. PubMed ID: 33096329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The association between outpatient continuation/maintenance electroconvulsive therapy, readmission risk and total direct cost in patients with depressive, bipolar and psychotic disorders: A naturalistic retrospective cohort study.
    Koh AHK; Tan XW; Tor PC; Chatterton ML; Martin DM; Loo CK
    J Affect Disord; 2023 Oct; 338():289-298. PubMed ID: 37295655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early- and Late-Onset Depression in Late Life: A Prospective Study on Clinical and Structural Brain Characteristics and Response to Electroconvulsive Therapy.
    Dols A; Bouckaert F; Sienaert P; Rhebergen D; Vansteelandt K; Ten Kate M; de Winter FL; Comijs HC; Emsell L; Oudega ML; van Exel E; Schouws S; Obbels J; Wattjes M; Barkhof F; Eikelenboom P; Vandenbulcke M; Stek ML
    Am J Geriatr Psychiatry; 2017 Feb; 25(2):178-189. PubMed ID: 27771245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transient Cognitive Impairment and White Matter Hyperintensities in Severely Depressed Older Patients Treated With Electroconvulsive Therapy.
    Wagenmakers MJ; Vansteelandt K; van Exel E; Postma R; Schouws SNTM; Obbels J; Rhebergen D; Bouckaert F; Stek ML; Barkhof F; Beekman ATF; Veltman DJ; Sienaert P; Dols A; Oudega ML
    Am J Geriatr Psychiatry; 2021 Nov; 29(11):1117-1128. PubMed ID: 33454176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient, treatment, and anatomical predictors of outcome in electroconvulsive therapy: a prospective study.
    van Waarde JA; van Oudheusden LJ; Heslinga OB; Verwey B; van der Mast RC; Giltay E
    J ECT; 2013 Jun; 29(2):113-21. PubMed ID: 23475028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Performance of the Psychotic Depression Assessment Scale as a Predictor of ECT Outcome.
    van Diermen L; Versyck P; van den Ameele S; Madani Y; Vermeulen T; Fransen E; Sabbe BGC; van der Mast RC; Birkenhäger TK; Schrijvers D
    J ECT; 2019 Dec; 35(4):238-244. PubMed ID: 31764446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relapse after abrupt discontinuation of maintenance electroconvulsive therapy during the COVID-19 pandemic.
    Lambrichts S; Vansteelandt K; Crauwels B; Obbels J; Pilato E; Denduyver J; Ernes K; Maebe PP; Migchels C; Roosen L; Buggenhout S; Bouckaert F; Schrijvers D; Sienaert P
    Acta Psychiatr Scand; 2021 Sep; 144(3):230-237. PubMed ID: 34086984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Grey matter volume increase following electroconvulsive therapy in patients with late life depression: a longitudinal MRI study.
    Bouckaert F; De Winter FL; Emsell L; Dols A; Rhebergen D; Wampers M; Sunaert S; Stek M; Sienaert P; Vandenbulcke M
    J Psychiatry Neurosci; 2016 Mar; 41(2):105-14. PubMed ID: 26395813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.